Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2034-2034
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Metabolic dysfunction-associated steatotic liver disease and its link to cancer
Markos Kalligeros, Linda Henry, Zobair M. Younossi
Metabolism (2024) Vol. 160, pp. 156004-156004
Closed Access | Times Cited: 18
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2761-2761
Open Access | Times Cited: 35
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
Reem Ezzat, Mohamed Eltabbakh, Mohamed El‐Kassas
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 12, pp. 1919-1938
Open Access | Times Cited: 47
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
Byeong Geun Song, Sung C. Choi, Myung Ji Goh, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100810-100810
Open Access | Times Cited: 18
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial
Paola Mogna-Peláez, José Ignacio Riezu‐Boj, Fermı́n I. Milagro, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1770-1781
Open Access | Times Cited: 6
Endoplasmic reticulum stress PERK-ATF4-CHOP pathway is involved in non-alcoholic fatty liver disease in type 1 diabetic rats: The rescue effect of treatment exercise and insulin-like growth factor I
Shadi Mohammadpour-Asl, Behrad Roshan-Milani, Shiva Roshan‐Milani, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27225-e27225
Open Access | Times Cited: 5
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
S. Panneerselvam, Cornelia M. Wilson, Prem Kumar, et al.
Cell Adhesion & Migration (2023) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
Disturbed intracellular folate homeostasis impairs autophagic flux and increases hepatocytic lipid accumulation
W. Chi, Gang-Hui Lee, Ming‐Jer Tang, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Analysis of influencing factors of washed microbiota transplantation in treating patients with metabolic syndrome
De-Jiang Lin, Dongxia Hu, Qingting Wu, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis
Zobair M. Younossi, Linda Henry
Endocrine Practice (2021) Vol. 28, Iss. 2, pp. 204-213
Closed Access | Times Cited: 24
Mitophagy in metabolic syndrome
Mei‐Qi Miao, Yubo Han, Li Liu
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 5, pp. 397-403
Open Access | Times Cited: 10
Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
Mădălina-Gabriela Țâru, Monica Lupșor‐Platon
Cancers (2023) Vol. 15, Iss. 16, pp. 4097-4097
Open Access | Times Cited: 9
Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Landon L. Chan, Stephen L. Chan
Cancers (2022) Vol. 14, Iss. 6, pp. 1526-1526
Open Access | Times Cited: 13
Pathogenesis from Inflammation to Cancer in NASH-Derived HCC
Simiao Yu, Jingxiao Wang, Haocheng Zheng, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 855-867
Open Access | Times Cited: 13
Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Mirela-Georgiana Perné, Adela Sitar-Tăut, Teodora Alexescu, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 6
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3257-3257
Open Access | Times Cited: 12
Improvement of hepatic innate immunity in chemically-injured livers to develop hepatocarcinoma by a serine type-protease inhibitors enriched extract from Chenopodium quinoa
Maria Alicia Rueda Huélamo, Alba Martínez Perlado, Valeria Consoli, et al.
Food & Function (2024) Vol. 15, Iss. 7, pp. 3600-3614
Closed Access | Times Cited: 1
Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study
Thandar Oo, Noboru Sasaki, Yoshinori Ikenaka, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 7
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention
Massimiliano Cadamuro, Mario Strazzabosco
Advances in cancer research (2022), pp. 39-73
Closed Access | Times Cited: 6
Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease
Dimitrios Kotsos, Κωνσταντίνος Τζιόμαλος
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3049-3049
Open Access | Times Cited: 3
Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study
Chang Hong, Chengkai Wu, Pengcheng Ma, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
A Cross-Sectional Study of the Correlation Between the Atherogenic Index of Plasma and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes
Jie Lin, Hang Li, Qin Wan
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2227-2234
Open Access | Times Cited: 5
The past, present and future of liver cancer control for Māori
Jason Gurney, Sydney Clough, Tara Cleverley, et al.
New Zealand medical journal (2022) Vol. 135, Iss. 1567, pp. 91-104
Open Access | Times Cited: 4
Physical activity and exercise in liver cancer☆
Haiyan Chen, Huimin Zhou, Bo Wu, et al.
Liver Research (2024) Vol. 8, Iss. 1, pp. 22-33
Open Access
Non-Alcoholic Fatty Liver Disease and the Risk of Future Hepatocarcinoma
Arnd Scholten
Science Insights (2024) Vol. 44, Iss. 5, pp. 1357-1364
Open Access
Page 1 - Next Page

Scroll to top